Markets:

Overview

News

Currencies

International

Treasuries

Lantheus Holdings, Inc. - Common Stock (NQ:LNTH)

77.80 -2.44 (-3.04%)

Streaming Delayed Price Updated: 11:32 AM EDT, Mar 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Lantheus Holdings, Inc. - Common Stock

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 27, 2021

Gainers Rezolute (NASDAQ:RZLT) shares rose 46.68% to $11.28 during Thursday's regular session. As of 12:30 EST, Rezolute's stock is trading at a volume of 1.4...

Via Benzinga

41 Stocks Moving In Thursday's Mid-Day Session ↗

May 27, 2021

Gainers 1847 Goedeker Inc. (NYSE: GOED) shares jumped 156.5% to $11.08 after dropping over 8% on Wednesday. Vertex Energy, Inc. (NASDAQ: VTNR) jumped 117% to $3.8604 after the...

Via Benzinga

Why Lantheus Stock Is Soaring Today ↗

May 27, 2021

Investors are cheering FDA approval for the company's prostate cancer imaging agent.

Via The Motley Fool

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

Stocks That Hit 52-Week Highs On Friday ↗

April 23, 2021

On Friday morning, 152 companies hit new 52-week highs. Things to Consider: The largest company by market cap to hit a new 52-week high was ASML Holding (NASDAQ:...

Via Benzinga

Lantheus Shares Trading Higher On FDA Approval For Imaging Agent For Identification Of Prostate Cancer ↗

May 27, 2021

The FDA has approved Lantheus Holdings Inc's (NASDAQ: LNTH) Pylarify, a positron emission tomography (PET) imaging agent, to identify suspected metastasis...

Via Benzinga

The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs ↗

May 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 26) I-Mab (NASDAQ: IMAB)...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 27, 2021

Gainers Zosano Pharma (NASDAQ:ZSAN) stock moved upwards by 22.59% to $0.91 during Thursday's pre-market session. The company's market cap stands at $97.3 million....

Via Benzinga

Lantheus Receives U.S. FDA Approval of PYLARIFY® (piflufolastat F 18) Injection, the First and Only Commercially Available PSMA PET Imaging Agent for Prostate Cancer

May 27, 2021

From Lantheus Holdings, Inc.

Via Business Wire

The Week Ahead In Biotech (May 23-29): Eton, Lantheus FDA Decisions, Adcom Test For Provention, Chiasma Data Presentation ↗

May 23, 2021

Biotech stocks advanced in the week ended May 21, as risk aversion forced traders to buy into defensives. As earnings news flow tapered, stocks took cues from clinical readouts.

Via Talk Markets

The Week Ahead In Biotech (May 23-29): Eton, Lantheus FDA Decisions, Adcom Test For Provention, Chiasma Data Presentation ↗

May 23, 2021

Biotech stocks advanced in the week ended May 21, as risk aversion forced traders to buy into defensives. As earnings news flow tapered, stocks took cues from clinical readouts....

Via Benzinga

Lantheus Holdings Announces Presentation Featuring 18F-DCFPyL PET/CT, its PSMA-Targeted Prostate Cancer Imaging Agent at the 2021 ASCO Annual Meeting

May 21, 2021

From Lantheus Holdings, Inc.

Via Business Wire

Lantheus Holdings to Present at the Jefferies Virtual Healthcare Conference

May 20, 2021

From Lantheus Holdings, Inc.

Via Business Wire

Lantheus Holdings Inc (LNTH) Q1 2021 Earnings Call Transcript ↗

May 04, 2021

LNTH earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Lantheus Holdings: Q1 Earnings Insights ↗

May 04, 2021

Shares of Lantheus Holdings (NASDAQ:LNTH) remained unaffected after the company reported Q1 results. Quarterly Results Earnings per share fell 86.11% over the past year to...

Via Benzinga

The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues ↗

May 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data ↗

May 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Lantheus Holdings, Inc. Reports First Quarter 2021 Financial Results

May 04, 2021

From Lantheus Holdings, Inc.

Via Business Wire

EXINI Diagnostics AB, a Lantheus Company, Receives CE Mark Clearance for aPROMISE in Europe

May 03, 2021

From Lantheus Holdings, Inc.

Via Business Wire

Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates ↗

May 01, 2021

Following a mixed month in April, the Food and Drug Administration sets out to review another slate of drugs in May. ACADIA Pharmaceuticals Inc.'s (NASDAQ: ACAD) Nuplazid...

Via Benzinga

Lantheus Grants Allegheny Health Network Exclusive Rights for the Use of its Microbubbles in Combination with Ultrasound Assisted Gene Therapy for the Development of a Proposed Treatment for Xerostomia

April 30, 2021

From Lantheus Holdings, Inc.

Via Business Wire

The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs ↗

April 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) AtriCure, Inc. (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx ↗

April 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:...

Via Benzinga

Lantheus Holdings to Host First Quarter 2021 Earnings Conference Call and Webcast on May 4, 2021 at 8:00 a.m. Eastern Time

April 20, 2021

From Lantheus Holdings, Inc.

Via Business Wire

The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping ↗

April 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc...

Via Benzinga

Lantheus Expands R&D Leadership Team with Key New Hires

April 07, 2021

From Lantheus Holdings, Inc.

Via Business Wire

The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout ↗

April 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

Topics Intellectual Property

The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs ↗

April 23, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 22) AtriCure, Inc. (NASDAQ:...

Via Benzinga

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.